vs
Side-by-side financial comparison of Angel Oak Mortgage REIT, Inc. (AOMR) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
Angel Oak Mortgage REIT, Inc. is the larger business by last-quarter revenue ($10.9M vs $6.5M, roughly 1.7× Prelude Therapeutics Inc). Angel Oak Mortgage REIT, Inc. runs the higher net margin — 103.9% vs -303.5%, a 407.3% gap on every dollar of revenue. On growth, Prelude Therapeutics Inc posted the faster year-over-year revenue change (116.7% vs 10.4%).
Angel Oak Mortgage REIT, Inc. is a U.S.-based real estate investment trust focused on investing in residential mortgage assets, including non-agency mortgage-backed securities, residential mortgage loans, and credit-linked real estate instruments. It serves U.S. institutional and retail investors, targeting competitive risk-adjusted returns through regular income and long-term capital growth.
AOMR vs PRLD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.9M | $6.5M |
| Net Profit | $11.3M | $-19.7M |
| Gross Margin | — | — |
| Operating Margin | — | -314.1% |
| Net Margin | 103.9% | -303.5% |
| Revenue YoY | 10.4% | 116.7% |
| Net Profit YoY | 175.2% | 38.9% |
| EPS (diluted) | $0.44 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $10.9M | — | ||
| Q3 25 | $10.2M | $6.5M | ||
| Q2 25 | $9.9M | — | ||
| Q1 25 | $10.1M | — | ||
| Q4 24 | $9.9M | — | ||
| Q3 24 | $9.0M | $3.0M | ||
| Q2 24 | $9.5M | — | ||
| Q1 24 | $8.6M | — |
| Q4 25 | $11.3M | — | ||
| Q3 25 | $11.4M | $-19.7M | ||
| Q2 25 | $767.0K | — | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | $-15.1M | — | ||
| Q3 24 | $31.2M | $-32.3M | ||
| Q2 24 | $-273.0K | — | ||
| Q1 24 | $12.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -314.1% | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -152.6% | — | ||
| Q3 24 | — | -1145.9% | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | — | — |
| Q4 25 | 103.9% | — | ||
| Q3 25 | 112.1% | -303.5% | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | 203.5% | — | ||
| Q4 24 | -152.6% | — | ||
| Q3 24 | 345.9% | -1075.7% | ||
| Q2 24 | -2.9% | — | ||
| Q1 24 | 150.1% | — |
| Q4 25 | $0.44 | — | ||
| Q3 25 | $0.46 | $-0.26 | ||
| Q2 25 | $0.03 | — | ||
| Q1 25 | $0.87 | — | ||
| Q4 24 | $-0.62 | — | ||
| Q3 24 | $1.29 | $-0.43 | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $0.51 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.6M | $55.0M |
| Total DebtLower is stronger | $2.3B | — |
| Stockholders' EquityBook value | $267.5M | $58.5M |
| Total Assets | $2.7B | $94.8M |
| Debt / EquityLower = less leverage | 8.51× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $41.6M | — | ||
| Q3 25 | $51.6M | $55.0M | ||
| Q2 25 | $40.5M | — | ||
| Q1 25 | $38.7M | — | ||
| Q4 24 | $40.8M | — | ||
| Q3 24 | $42.1M | $153.6M | ||
| Q2 24 | $44.0M | — | ||
| Q1 24 | $39.4M | — |
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $267.5M | — | ||
| Q3 25 | $264.2M | $58.5M | ||
| Q2 25 | $246.4M | — | ||
| Q1 25 | $251.5M | — | ||
| Q4 24 | $239.0M | — | ||
| Q3 24 | $265.1M | $156.4M | ||
| Q2 24 | $255.8M | — | ||
| Q1 24 | $263.3M | — |
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.6B | $94.8M | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.3B | $197.2M | ||
| Q2 24 | $2.1B | — | ||
| Q1 24 | $2.3B | — |
| Q4 25 | 8.51× | — | ||
| Q3 25 | 8.37× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-407.0M | $-19.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | -35.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-407.0M | — | ||
| Q3 25 | $-173.4M | $-19.1M | ||
| Q2 25 | $20.6M | — | ||
| Q1 25 | $-201.7M | — | ||
| Q4 24 | $-221.5M | — | ||
| Q3 24 | $-212.4M | $-27.3M | ||
| Q2 24 | $-24.2M | — | ||
| Q1 24 | $40.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-27.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -912.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -35.96× | — | ||
| Q3 25 | -15.19× | — | ||
| Q2 25 | 26.92× | — | ||
| Q1 25 | -9.83× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.81× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.12× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AOMR
| Nonrelated Party | $6.4M | 59% |
| Other | $4.5M | 41% |
PRLD
Segment breakdown not available.
